Ophthalmic Drugs Market Scope, Product Estimates & Strategy Framework To 2020

In December 2017, Spark Therapeutics received Food and Drug Administration (FDA) approval for the first gene therapy drug in the ophthalmic market-Luxturna (voretigene neparvovec-rzyl). The drug is indicated for ophthalmic diseases associated with RPE65 gene mutation, such as retinitis pigmentosa and Leber’s congenital amaurosis.

Download Free PDF Sample  - https://www.radiantinsights.com/research/ophthalmic--drugs-market/request-sample

Increasing number of strategic mergers, acquisitions, and collaborations make the market for ophthalmic drugs a highly competitive space. However, there is ample scope for consolidation. Premium services and high-volume ancillary value-added businesses deliver supplementary benefits to customers and attract investments in the market. The reimbursement policies for ophthalmic treatment form a diversifying factor in the market.

Companies are constantly launching new products to expand their product portfolio and to attain higher share. For instance, in July 2019, Bausch & Lomb Incorporated announced launch of Ocuvite, an eye vitamin supplement to strengthen the macula for the U.S. market.

Due to increasing awareness of ophthalmic disorders and surge in the demand of these products, ophthalmic drug manufacturers are expanding their presence in the emerging economies by supporting various awareness campaigns in different regions. For instance, in 2016, Alcon announced their support to a public awareness program, Think About Your Eyes. The company committed USD 4 million to support this initiative and to promote awareness pertaining to vision care.

Browse Full Report With TOC  - https://www.radiantinsights.com/research/ophthalmic--drugs-market

Further key findings from the study suggest:

• Anti-VEGF agents dominated the drug class segment in 2019 and is anticipated to register the fastest CAGR of 6.7% over the forecast period

• Retinal disorder held the largest market share in 2019 due to rising prevalence of diabetic retinopathy

• In 2019, macular degeneration was the largest retinal disorder segment and diabetic retinopathy was the fastest growing segment

• Eye drops held the leading ophthalmic drugs market share in 2019 and is projected to witness the highest CAGR during the forecast period as it is the most preferred form of drug delivery used for treating ocular diseases such as acute allergies, corneal ulcers, and glaucoma

Comments

Post a Comment

Popular posts from this blog

Corporate Wellness Market Demand And Industry Growth Till, 2022 - 2030.

The global  corporate wellness market  size is expected to reach USD 93.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.0% from 2021 to 2028. Rising obese and overweight population increases insurance costs that account for the financial burden on the employers. The corporate wellness initiatives target particular health risk factors such as stress, obesity, smoking, poor eating, and lack of exercise. The pandemic has caused a change in the process of delivering wellness services. Although in-person sessions have resumed to some extent, the virtual platform has been made available to at-risk employees to meet their psychological and fitness needs. Initially, the lockdown imposed due to COVID19 resulted in transition to work from home, causing a great deal of stress. Corporate Wellness Market Segmentation Grand View Research has segmented the global corporate wellness market on the basis of service, end-u...
Read more

Medical Device Validation & Verification Market Outlook Till, 2020-2027

The global medical device validation and verification market size is expected to reach USD 1.1 billion by 2027, expanding at a CAGR of 11.1% over the forecast period, according to a new report by Grand View Research, Inc. Download Free Sample -  https://www.radiantinsights.com/research/medical-device-validation-&-verification-market/request-sample Increase in demand for advanced and quality medical products and rising complexity with respect to product designing and engineering are anticipated to boost market growth. Rapid innovations in healthcare have increased the need for companies to incorporate new technologies and software applications in their products to meet the demand for validation and verification. Increase in product complexity, availability of newer types of material, and high risk of product failures are some of the key factors increasing the need for validation and verification services. North America dominated the global medical device validation and verificat...
Read more

Automotive Brake Systems Market Players And Industry Forecasts Till, 2014 - 2025.

Automotive brake systems are the technologies that combine brake controls and sensors to avoid high-speed road accidents. Some automotive brake systems are designed to simply reduce the speed of vehicles before hitting a roadblock while some brake systems completely avert the mishaps. Since high-speed collisions are more dangerous than the low-speed collisions, automotive braking systems saves lives and reduces the vehicle damage during a mishap. Most systems offer braking support to the driver while others adeptly activate the brakes with no driver input. Other factors like government regulations on reducing stopping distances, New Car Assessment Program (NCAP), safety rating certifications, and instructions on installation of electronic brake systems are increasing the demand for disc brakes and other automatic brake systems. Download  Free Sample  -  https://www.millioninsights.com/industry-reports/automotive-brake-system-market/request-sample The automotive brake syst...
Read more